(b)(6) study.It was reported that stent thrombosis and ischemia occurred.The subject underwent treatment with a study device on (b)(6) 2020 as part of the (b)(6) trial.The target lesion was located in left proximal superficial femoral artery (sfa) with 100% stenosis.The lesion was 100 mm long with a proximal reference vessel of 5 mm and a distal reference vessel diameter of 5 mm and was classified as a tasc ii a lesion.The target lesion was treated with pre-dilatation followed by placement of four 6 mm x 120 mm stents.Following post dilation, the residual stenosis was 0%.On (b)(6) 2020, the subject was discharged on dual antiplatelet therapy.On (b)(6) 2020, dissection flap in the target vessel.On (b)(6) 2020, the subject was hospitalized due to ischemia in left leg.Diagnosis revealed presence of thrombus in the stent.Subsequently, the subject also developed myocardial infarction for which medication was given as a treatment.No treatment was given for ischemia in target limb.On (b)(6) 2020, the subject died due to myocardial infarction unrelated to the stent.The event was considered not recovered/ not resolved.
|